Hypersensitivity and allergy testing
15 min
- Classify a hypersensitivity reaction by its main effector mechanism
- Distinguish allergen sensitization from clinical allergy
- Compare an acute tryptase with the patient's own baseline
Try first
Get the idea
Four mechanisms
The Gell and Coombs scheme sorts a hypersensitivity reaction by the immune effector that does most of the damage. Many diseases mix mechanisms, and the type names the main one.1
| Type | Main effector | Typical timing | Example |
|---|---|---|---|
| I, immediate | Allergen-specific IgE on mast cells and basophils | Minutes | Anaphylaxis to a bee sting |
| II, antibody against a fixed antigen | IgG or IgM bound to a cell, matrix or receptor | Hours to days | Anti-GBM disease, myasthenia gravis |
| III, immune complex | Soluble antigen-antibody complexes deposited in tissue | Days after exposure | Serum sickness |
| IV, cell mediated | Sensitized T cells and macrophages | 24 to 72 hours | Contact dermatitis, tuberculin skin test |
Types II and III both use antibody. In type II the antibody binds antigen fixed in place, such as a basement membrane or a receptor. In type III the complexes form in the circulation and lodge in vessel walls, where they activate complement and can lower C3 and C4.1
Sensitization and allergy
A positive allergen-specific IgE or skin test shows sensitization. The patient has made IgE to that allergen. Whether the IgE explains a reaction depends on the exposure and the reaction history. Many sensitized people tolerate the allergen with no symptoms. Total IgE rises in many conditions and cannot name the allergen responsible.2
Tryptase against the patient's own baseline
Mast cells release tryptase when they degranulate. The acute serum tryptase is drawn as early as practical after a suspected anaphylactic reaction, and a baseline is drawn later when the patient is well. One criterion supporting mast-cell activation is an acute tryptase (ng/mL) greater than 1.2 × baseline tryptase (ng/mL) + 2 ng/mL, with the acute specimen drawn ideally within 2 hours of symptom onset and the baseline when the patient is well. An acute result within the reference interval does not exclude anaphylaxis.3
The criterion compares the acute result with the patient's own baseline. A baseline of 4.0 ng/mL gives a threshold of 6.8 ng/mL, so an acute result of 8 ng/mL can meet the criterion and still sit inside the reference interval. Each result is reported with its collection time, because the two are read as a pair.3
References
- Abbas AK, Lichtman AH, Pillai S, Henrickson S. Cellular and Molecular Immunology. 11th ed. Elsevier; 2025. Elsevier.
- Ansotegui IJ, Melioli G, Canonica GW, et al. IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper. World Allergy Organ J. 2020;13(2):100080. doi:10.1016/j.waojou.2019.100080
- Golden DBK, Wang J, Waserman S, et al. Anaphylaxis: a 2023 practice parameter update. Ann Allergy Asthma Immunol. 2024;132(2):124-176. doi:10.1016/j.anai.2023.09.015
Watch one
Imani Castellanos, 35, a wedding florist, develops hives and wheezing minutes after eating a cashew. An acute tryptase is drawn in the emergency department. A baseline is drawn 4 weeks later.
Does the acute tryptase meet the criterion for mast-cell activation?
| Test | Result | Previous | Reference interval | Flag |
|---|---|---|---|---|
| Tryptase, acute | 8.1 ng/mL | <11.5 ng/mL | ||
| Tryptase, baseline | 4.0 ng/mL | <11.5 ng/mL |
Specimen: H 3, L 10, I 1. Acute serum collected 1 hour 15 minutes after symptom onset; baseline serum collected 4 weeks later
- Check the acute collection time first. It was drawn 1 hour 15 minutes after onset, inside the recommended 2 hours.
Tryptase peaks early and falls over hours, so a late acute draw can miss the rise.
- Check the baseline. It was drawn 4 weeks later, when she was well.
A baseline drawn during the reaction would already be raised and would hide the rise.
- Multiply the baseline: 1.2 × 4.0 ng/mL = 4.8 ng/mL.
The criterion scales the patient's own baseline first.
- Add 2 ng/mL: 4.8 + 2 = 6.8 ng/mL.
The added 2 ng/mL allows for normal variation between specimens.
- Compare: 8.1 ng/mL is greater than 6.8 ng/mL.
The acute result is judged against the patient's threshold.
- Note that both results sit inside the reference interval. The flag column alone would have missed the rise.
The population interval describes other people at rest and misses a rise from a low baseline.
Your turn
Use it
- Tomasz Wierzbicki, 29, keeps six hives of bees on his roof.
- Last week a honeybee stung his hand. Within minutes he had hives, wheezing and low blood pressure.
- The emergency department drew an acute tryptase 1 hour after the sting.
- A baseline tryptase and venom-specific IgE were drawn 3 weeks later.
- He says a wasp has never stung him.
| Test | Result | Previous | Reference interval | Flag |
|---|---|---|---|---|
| Tryptase, acute | 10.4 ng/mL | <11.5 ng/mL | ||
| Tryptase, baseline | 6.0 ng/mL | <11.5 ng/mL | ||
| Honeybee venom IgE | 3.2 kU/L | <0.35 kU/L | High | |
| Wasp venom IgE | 0.9 kU/L | <0.35 kU/L | High |
Specimen: H 2, L 8, I 1. Acute serum 1 hour after the sting; baseline and venom IgE serum 3 weeks later
The clue that settled this case is his own baseline tryptase. At 6.0 ng/mL it sets a threshold of 9.2 ng/mL, so an acute 10.4 ng/mL shows mast-cell activation. Neither result carries a flag. The venom IgE results show sensitization, and only the honeybee result matches a reaction he has had.
Results
- Classify a hypersensitivity reaction by its main effector mechanism
- Distinguish allergen sensitization from clinical allergy
- Compare an acute tryptase with the patient's own baseline
To review
6 questions from this step will come back in Review.
Next step: Plasma cell disorders, cryoglobulins and tumor immunityReview nowOpen the part
Keep
Sources checked
The rest of this step
A short briefing, a demonstration at the bench, 3 practice problems and a short case.
A free account opens the rest and keeps your progress.